In two separate studies, Rangaka et al. found that assay responses to RD1 antigens were not significantly impaired in two cohorts of patients with latent infection and moderate HIV-associated immunodeficiency (both median CD4 cell counts of 392 cells/μl and 464 cells/μl) [20,21]. Here, PDE6B is linked to disease arising from reactivation of latent virus.